MONAS
FINANCIAL
Home
About
Research
Data
Pricing
Team
News
Analysis
Press
Contact
Legal
← News
Goldman Sachs Maintains Buy on Amgen, Raises Price Target to $536
Analyst Ratings
AMGN
Nov 4
AI-curated analysis for informational purposes only — not investment advice.
Goldman Sachs Maintains Buy on Amgen, Raises Price Target to $536
Read the full story at benzinga.com →